These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Adial Pharmaceuticals (ADIL), 2,010% surge in interest Alpine Immune
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Adial Pharmaceuticals (ADIL), 2,010% surge in interest Alpine Immune
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Palatin Technologies (PTN), 1,002% surge in interest Leap Therapeutics
Syros Pharmaceuticals announced that the United States Food and Drug Administration, FDA, has granted Fast Track Designation, FTD, to tamibarotene in combination with azacitidine and venetoclax for the treatment of
Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Syros Pharmaceuticals (SYRS – Research Report) today and set a price target of $13.00. The company’s shares closed yesterday at
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Syros Pharmaceuticals (SYRS – Research Report), with a price target of $15.00. Andrew Fein has